These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2122131)

  • 41. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer].
    Maeta M; Koga S; Shimizu N; Osaki Y; Kanayama H; Hamazoe R; Yamane T; Karino T; Oda M
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2370-6. PubMed ID: 6416183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
    Maehara Y; Okuyama T; Kakeji Y; Baba H; Furusawa M; Sugimachi K
    Am J Surg; 1994 Jul; 168(1):36-40. PubMed ID: 8024097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.
    Niimoto M; Saeki T; Toi M; Nishiyama M; Hirai T; Yanagawa E; Hattori T
    Jpn J Surg; 1990 Mar; 20(2):186-91. PubMed ID: 2111415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
    Kato M; Kinoshita K; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Segawa M; Ohyama S; Yonemura Y; Miwa K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):391-6. PubMed ID: 2106835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients.
    Hattori T; Niimoto M; Koh T; Nakano A; Oride M; Takiyama W; Nishimawari K
    Jpn J Surg; 1979 Jun; 9(2):110-7. PubMed ID: 376911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
    Inoue Y; Nasu H; Nakamura J; Arakawa H; Masamune O; Yamada N; Furuya M; Ookubo M; Mukojima T; Koizumi R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3567-72. PubMed ID: 2510604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of postoperative long-term cancer chemotherapy (PLCC) on non-curative gastric cancer of stage IV].
    Kano T; Tamada R; Notsuka T; Hiramoto Y; Abe Y; Shiraishi M; Inoue F; Kumashiro R; Kodama Y; Inokuchi K
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):710-5. PubMed ID: 7184422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
    Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
    Toge T; Yamaguchi Y
    Oncol Rep; 2000; 7(5):1157-61. PubMed ID: 10948356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy].
    Sano T; Nomura K; Adachi M; Kobori O
    Gan No Rinsho; 1990 Jan; 36(1):97-100. PubMed ID: 2105405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term administration of tegafur in postoperative adjuvant chemotherapy in gastric cancer patients. Serial analysis of serum tegafur and 5-fluorouracil concentrations, and influence from PSK combination].
    Tanaka T; Kitao T; Furutani M; Harada T; Hayashi S; Matsushita T; Asada I; Shirosaki H
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):95-9. PubMed ID: 2492184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
    Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
    Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I.
    Niimoto M; Hattori T; Ito I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M
    Cancer Immunol Immunother; 1984; 18(1):13-8. PubMed ID: 6435856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer].
    Nakazato H; Koike A; Ichihashi H
    Gan No Rinsho; 1986 Feb; 32(2):159-64. PubMed ID: 3083146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy of unresectable Borrmann type 4 gastric cancer].
    Izumi T; Kurihara M; Maruyama T; Sasaki Y; Shirakabe H
    Gan No Rinsho; 1984 May; 30(6 Suppl):710-6. PubMed ID: 6431141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
    Taguchi T; Usugane M; Inokuchi K; Hattori T; Inoue K; Kondo T; Akiyama H; Abe O; Nakajima T; Muto T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1833-9. PubMed ID: 3929692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy].
    Ichihashi H; Yamauchi M; Watanabe T; Takagi H; Kondo T
    Gan No Rinsho; 1988 Apr; 34(4):451-6. PubMed ID: 3128670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.